Заключение Совета экспертов.  Сердечно-сосудистые заболевания  и сахарный диабет 2 типа: новые  возможности снижения смертности

I. V. Sergienko; A. S. Ametov; M. B. Antsiferov; Yu. Sh. Khalimov; M. I. Voevoda; G. R. Galstyan; A. S. Galyavich; D. V. Duplyakov; A. G. Obrezan; A. A. Ansheles; S. N. Tereschenko; O. M. Drapkina; V. V. Kukharchuk; S. A. Boytsov

Consensus Statement. Cardiovascular diseases and type 2 diabetes mellitus: new opportunities for reducing mortality

Authors

I. V. Sergienko FSU Russian Cardiological Research and Production Complex of the Ministry of Health of the Russian Federation
A. S. Ametov Russian Medical Academy of Continuous Professional Education
M. B. Antsiferov Endocrinology dispensary, Moscow Health Department
Yu. Sh. Khalimov Military medical academy of S.M. Kirov
M. I. Voevoda Research Center of Therapy and Preventive Medicine
G. R. Galstyan Endocrinology Research Centre
A. S. Galyavich Казанский государственный медицинский университет
D. V. Duplyakov Samara Region Clinical Cardiological Dispensary
A. G. Obrezan St. Petersburg State University
A. A. Ansheles National Medical Research Center of Cardiology
S. N. Tereschenko National Medical Research Center of Cardiology
O. M. Drapkina NationalResearchCenterforPreventiveMedicine
V. V. Kukharchuk National Medical Research Center of Cardiology
S. A. Boytsov National Medical Research Center of Cardiology

Keywords:

type 2 diabetes, cardiovascular risk, empagliflozin

Abstract

In the current Consensus Statement a discussion of the extremely topical issue of treating patients with type 2 diabetes and cardiovascular pathology is presented. The reason for this discussion was the emergence of a new glucose-lowering drug, SGLT2 inhibitor empagliflozin, and its inclusion in foreign and Russian recommendations for management of patients with diabetes mellitus. This drug is considered as first-line when type 2 diabetes mellitus is combined with ischemic heart disease and/or circulatory insufficiency. A special focus in the current Consensus Statement is on the EMPA-REG OUTCOME trial.

Downloads

Download data is not yet available.

Downloads

PDF (Русский)

Published

2018-09-25

How to Cite

Sergienko I. V., Ametov A. S., Antsiferov M. B., Khalimov Y. S., Voevoda M. I., Galstyan G. R., Galyavich A. S., Duplyakov D. V., Obrezan A. G., Ansheles A. A., Tereschenko S. N., Drapkina O. M., Kukharchuk V. V., Boytsov S. A. Consensus Statement. Cardiovascular diseases and type 2 diabetes mellitus: new opportunities for reducing mortality // The Journal of Atherosclerosis and Dyslipidemias. 2018. VOL. № 3 (32). PP. 68–72.

MLA
GOST

Download Citation

Issue

No. 3 (32) (2018)

Section

Miscellaneous

Most read articles by the same author(s)

M. V. Ezhov, I. V. Sergienko, V. V. Kukharchuk, Clinical guidelines for lipid disorders 2023. What's new? , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (52) (2023)
M. V. Ezhov, I. V. Sergienko, N. M. Akhmedzhanov, V. S. Gurevich, A. G. Obrezan, Dyslipidemia 2022 – how to reduce the risk and achieve the goal? , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (48) (2022)
V. V. Kukharchuk, M. V. Ezhov, I. V. Sergienko, G. G. Arabidze, M. G. Bubnova, T. V. Balakhonova, V. S. Gurevich, M. A. Kachkovsky, G. A. Konovalov, V. O. Konstantinov, P. P. Malyshev , S. D. Pokrovsky, A. A. Sokolov, A. B. Sumarokov, N. B. Gornyakova, A. G. Obrezan, I. I. Shaposhnik, M. B. Antsiferov, A. A. Ansheles, D. M. Aronov, N. M. Akhmedzhanov, O. L. Barbarash , S. A. Boitsov, M. I. Voivoda, G. R. Galstyan, A. S. Galyavich, O. M. Drapkina, D. V. Duplyakov, S. Ya. Eregin, R. S. Karpov, Yu. A. Karpov, N. A. Koziolova, E. D. Kosmachev, D. V. Nebieridze, S. V. Nedogoda, V. E. Oleynikov, Yu. I. Ragino, V. V. Skibitsky, O. G. Smolenskaya, A. E. Filippov, Yu. Sh. Halimov, I. E. Chazova, M. V. Shestakova, S. S. Yakushin, Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Moscow, 2020 , The Journal of Atherosclerosis and Dyslipidemias: No. 1 (38) (2020)
I. V. Sergienko, M. V. Ezhov, V. S. Gurevich, V. K. Zafiraki, P. A. Barov, O. V. Tsygankova, E. A. Tsyplenkova, E. P. Prikhodko, N. G. Vinogradova, V. R. Idiyatullina, E. V. Vyrupaeva, M. V. Savchenko, Yu. E. Yukhina, A. A. Kalinovskaya, E. S. Timoshchenko, A. A. Nekrasov, O. G. Smolenskaya, K. S. Manko, E. V. Timoshina, Comparative efficacy and safety of statin monotherapy and their combination with ezetimibe (Results of the Russian retrospective observational study UNISON) , The Journal of Atherosclerosis and Dyslipidemias: No. 4 (49) (2022)
U. V. Chubykina, M. V. Ezhov, T. A. Rozhkova , B. M. Tamaeva, A. A. Sokolov, A. I. Ershova, A. N Meshkov, V. I. Mikhailina, A. V. Blokhina, A. S. Limonova, O. V. Kopylova, I. I. Shaposhnik, V. V. Genkel , V. S. Gurevich, S. A. Urazgildeeva, A. V. Tregubov, M. V. Muzalevskaya, M. I. Voevoda, O. V. Timoshchenko, E. V. Shakhtshneider, Yu. I. Ragino, I. V. Leontyeva, L. V. Egorov, I. N. Zakharova, I.I. Pshenichnikova, D. I. Sadykova, E. S. Slastnikova, L. F. Galimova, E. D. Kosmacheva, A. M. Namitokov, A. S. Alieva, A. S. Galyavich, Z. F. Kim, V. A. Korneva, T. Yu. Kuznetsova, A. E. Filippov, A. M. Tuktarov, A. S. Vorobyov, I. D. Astrakhantseva, D. Yu. Bogdanov, M. A. Kachkovsky, A. V. Egorova, V. O. Konstantinov, M. P. Serebrenitskaya, V. K. Zafiraki, N. N. Bizyaeva, N. G. Androsyuk, M. A. Kiseleva, Yu. G. Grigorieva, O.Yu. Korennova, Yu. E. Yukhina, M. D. Devyatova, O. N. Ivanova, P. A. Vasiliev, I. V. Avdeeva, V. E. Oleinikov, Yu. A. Vorobieva, Yu. A. Ermakova, N. V. Mukha, D. N. Zaitsev, M. V. Zykov, A.V. Isaeva, T. I. Petelina, E. V. Mikova, A five-year follow-up period in homo- and heterozygous familial hypercholesterolemia patients of the RENAISSANCE registry , The Journal of Atherosclerosis and Dyslipidemias: No. 1(50) (2023)
M. V. Ezhov, S. S. Bazhan, A. I. Ershova, A. N. Meshkov, A. A. Sokolov, V. V. Kukharchuk, V. S. Gurevich, M. I. Voevoda, I. V. Sergienko, E. V. Shakhtshneider, S. N. Pokrovsky, G. A. Konovalov, I. V. Leontyeva, V. O. Konstantinov, M. Yu. Shcherbakova, I. N. Zakharova, T. V. Balakhonova, A. E. Filippov, N. M. Akhmedzhanov, O. Yu. Aleksandrova, B. M. Lipovetsky, Clinical guidelines for familial hypercholesterolemia , The Journal of Atherosclerosis and Dyslipidemias: No. 1 (34) (2019)
I. V. Sergienko, M. V. Shestakova, S. A. Boystov, A. S. Ametov, M. B. Antsiferov, V. V. Kukharchuk, D. A. Zateishchikov, M. V. Ezhov, V. S. Gurevich, A. S. Galyavich, M. I. Voevoda, D. V. Duplyakov, O. L. Barbarash, Yu. Sh. Khalimov, G. P. Arutyunov, Yu. A. Karpov, M. G. Bubnova, L. Yu. Drozdova, A. A. Ansheles, I. V. Samorodskaya, N. A. Koziolova, O. M. Drapkina, Extreme risk category in the stratification system cardiovascular complications , The Journal of Atherosclerosis and Dyslipidemias: No. 4 (33) (2018)
M. V. Ezhov, I. V. Sergienko, D. M. Aronov, G. G. Arabidze, N. M. Akhmedzhanov, S. S. Bazhan, T. V. Balakhonova, O. L. Barbarash, S. A. Boytsov, M. G. Бубнова Bubnova, M. I. Voevoda, A. S. Galyavich, N. B. Gornyakova, V. S. Gurevich, O. M. Drapkina, D. V. Duplyakov, S. Ya. Yeregin, M. Yu. Zubareva, R.S. Karpov, Yu. A. Karpov, N. A. Koziolova, G. A. Konovalov, V. O. Konstantinov, E. D. Kosmacheva, A. I. Martynov, D. V. Nebieridze, S. N. Pokrovsky, Yu. I. Ragino, V. V. Skibitsky, O. G. Smolenskaya, I. E. Chazova, S. A. Shalnova, I. I. Shaposhnik, V. V. Kukharchuk , Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations VI revision , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (28) (2017)
I. V. Sergienko, A. A. Ansheles, S. A. Boytsov, Risk factors, lipid profile indicators and hypolipidemic therapy in patients of various categories of cardiovascular risk: the results of the Aterostop registry , The Journal of Atherosclerosis and Dyslipidemias: No. 2 (51) (2023)
V. N. Titov, S. A. Boitsov, S. J. Urazalina , I. V. Sergienko, E. Yu. Andreyenko, V. V. Kukharchuk, Iu. A. Karpov, Relationship of uric acid and lipid metabolism in patients with low and moderate risk , The Journal of Atherosclerosis and Dyslipidemias: No. 2 (11) (2013)

1 2 3 4 5 6 7 8 9 10 > >>

Consensus Statement. Cardiovascular diseases and type 2 diabetes mellitus: new opportunities for reducing mortality

Authors

Keywords:

Abstract

Downloads

Downloads

Published

How to Cite

Issue

Section

Most read articles by the same author(s)

Language

Make a Submission

Information

Indexing

Editor-in-chief

Rating

Current Issue